Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2020 March;45(1) > Minerva Endocrinologica 2020 March;45(1):29-35

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

ORIGINAL ARTICLE   

Minerva Endocrinologica 2020 March;45(1):29-35

DOI: 10.23736/S0391-1977.18.02914-0

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Improving effect of vitamin D supplementation on obesity-related diabetes in rats

Yanfang GUO 1, Ling ZHU 1, Yi GE 1, Hao ZHANG 2

1 Department of Pediatrics, Gongli Hospital, Second Military Medical University, Shanghai, China; 2 Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China



BACKGROUND: Vitamin D, a fat-soluble secosteroid, plays a key role in several metabolic diseases like diabetes. Diabetes is becoming a third leading chronic disease in the world, which seriously threatens human health.
METHODS: In the current study, we found the beneficial effects of vitamin D supplementation in obesity-related diabetes rat. Enzyme-linked immunosorbent assay, biochemical testing, real-time PCR and western blot were carried to investigate the effect of vitamin D supplementation on diabetes.
RESULTS: Successful modeling of obesity-related diabetes was determined by significant weight loss and elevated levels of fasting blood glucose, glycated hemoglobin and blood lipids at 12 weeks. Supplementation of vitamin D obviously increased body weight and decreased fasting blood glucose, glycated hemoglobin, and blood lipids, accompanied by increased 25-hydroxyvitamin D and decreased insulin, parathormone and adipocytokines. Furthermore, low expressed insulin receptor substrate-1 (IRS-1)/phosphorylation of IRS-1 (p-IRS-1), glucose transporter type 4 (GluT4) and vitamin D receptor (VDR) was increased.
CONCLUSIONS: These suggested the beneficial effects of vitamin D supplementation in obesity-related diabetes rat, which may through VDR, IRS-1/p-IRS-1, and GluT4 signaling activation.


KEY WORDS: Insulin receptor substrate proteins; Streptozocin; Vitamin D

top of page